Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.815 USD | +1.62% | 0.00% | +67.06% |
05-07 | Transcript : Heron Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
05-07 | Heron Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+67.06% | 417M | |
+27.14% | 44.96B | |
+0.10% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.19% | 26.08B | |
-21.07% | 19.03B | |
+6.42% | 12.75B | |
+28.75% | 12.06B | |
-3.71% | 11.75B |
- Stock Market
- Equities
- HRTX Stock
- News Heron Therapeutics, Inc.
- Needham Adjusts Price Target on Heron Therapeutics to $7 From $8, Keeps Buy Rating